Intragastric Balloons Market By Application (Single Balloons, Double Balloons, Triple Balloons, Others), By Usage Area (Hospitals, Ambulatory Centers, Private Clinics) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Obesity is a complex medical condition that leads to critical health complications such as diabetes, heart disease, high blood pressure, and more. The prevalence of obesity and the comorbid diseases associated with overeating and obesity should drive the global market. According to the World Health Organization (WHO), the global obese population has tripled since 1975. In the report of the WHO (2016), 1.9 Bn adults, 18 years of age and older, were overweight, and of these, 650 Mn were obese. Around the globe, around 2.8 million people die each year due to obesity, and approximately 35.8 million (2.3%) of global DALYs are due to obesity or excessive weight. Due to the heavy costs associated with obesity, there is a great impact on the healthcare system around the globe. Advancements in technology, better treatment availability for obesity, and rapid growth in the prevalence of obesity in the population will enhance the adoption of intragastric balloons as a perfect treatment, which will lead to the growth of the intragastric balloons market in the coming years.

The scope of the study titled "Intragastric Balloons Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" provides manufacturers, business executives, and shareholders with a comprehensive study helping them in designing the roadmap associated with the anticipation in the global intragastric balloons market and to help them in taking collaborative decisions. This report investigates and provides the most recent trends in the global intragastric balloons market, as well as market forecast and size.

The research study is made up of different types of balloons and their geographical distribution. The intragastric balloon types are categorized into single balloons, double balloons, and triple balloons. Detailed research in terms of forecast and market size is done for a particular category for the period 2015–2025, and specific CAGRs for the period 2017–2025 are also available in the report.

This research report also includes geographical sections accompanied by the foremost countries, which are alluded to as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The report covers a detailed description of the above-stated market segments for the period of 2015–2025, along with a specific market assessment for the individual countries in their region-wise segments.

A detailed analysis of market dynamics has been mentioned in the report to get a proper understanding of the market and the associated trends. Various tools are used in the report to demonstrate the analysis by the main players. The study also consists of a company profile of the organizations that have a stronghold in the global market for intragastric balloons. Some of the main players in the global intragastric balloons market are listed below: Apollo Endosurgery, Allurion Technologies, Lexal Srl, Districlass Medical SA, Life Partners Europe, Feng Medical, Medsil, Obalon Therapeutics, Phagia Technologies, PlenSat, ReShape Medical, Silimed, Spatz FGIA Inc., and Tulip Medical.

The global intragastric balloons market is being studied for their application in the following areas for the purposes of this study:

  • Single Balloons
  • Double Balloons
  • Triple Balloons
  • Others

At present, obesity is one of the leading factors contributing to considerable costs, morbidity, and mortality in the U.S. According to the U.S. Department of Health and Services, the prevalence of obesity was 36.5% among U.S. adults during 2011–14. The National Institute of Health also reported that excessive weight and obesity together are the second leading cause of death in the U.S.; approximately 300,000 deaths occur per year due to obesity. Technological advancement and medically advanced procedures are driving the intragastric balloons market. Another chief factor enhancing the market for intragastric balloons is the increase in life expectancy.

Intragastric balloons are a viable alternative to traditional bariatric surgery, providing a non-invasive method to lose weight without any surgical procedure and with a higher efficacy rate. According to research, the highest weight categories have an increased 40% to 90% chance of dying from cancer. Higher mortality rates from cardiovascular diseases and cancer are closely associated with obesity; an increase in demand for non-invasive procedures is boosting the growth of the intragastric balloon market. Growing healthcare sectors and technological advancement are also some of the main drivers for the growth of this market.

The global intragastric balloons market is being studied for their application in the following usage areas for the purposes of this study:

  • Hospitals
  • Ambulatory Centers
  • Private Clinics

Among the considered usage areas, intragastric balloons enjoy the largest application in hospitals, followed by ambulatory centers. Higher affordability of hospitals in terms of the purchase of intragastric balloons, greater handling skills, and a higher cost-benefit ratio due to better patient footfall are the main factors driving the adoption of intragastric balloon systems in hospitals. It is further expected that due to the increasing preference of patients for approaching specialized private clinics for their requirements owing to faster turnaround times and better treatment outcomes, the demand for intragastric balloons from private clinics will be higher during the forecast period. Therefore, it is expected that the growth of the private clinic segment will be greater than the global benchmark during the forecast period.

North America holds the prime share in the global intragastric balloons market, pursued by Asia Pacific, attributable to major reasons such as the high prevalence of obesity in North America. Obesity prevalence was twice as high in high-wage and higher-middle-wage countries as it was in low- and lower-middle-wage countries. The distinction more than triples from 7% obesity in both genders in the lower middle-income nations to 24% in the higher middle-income nations. Obesity in women is essentially higher than in men, except in high-income nations where it is comparable. In low- and middle-income countries, women were roughly twice as likely as men to be overweight.

The intragastric balloon procedure is claimed to be completely secure and non-invasive. The demand for non-invasive procedures is expected to grow in the coming years. In the course of the forecast duration of 2017–2025, Asia Pacific is observed as the fastest-growing region due to key driving factors such as the rising prevalence of obesity in developing countries, increasing consciousness related to early treatment, evolving healthcare expenditure, and intensifying demand for non-invasive procedures.

The geographical classification of the global intragastric balloon market is as follows:

  • North America (Canada and the United States)
  • Asia Pacific (Japan, China, India, and the Rest of Asia Pacific)
  • Europe (France, Italy, Germany, the U.K., Spain, and the Rest of Europe)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Questions:

The market for Intragastric Balloons Market is expected to reach US$ 248 Mn by 2025.

The Intragastric Balloons Market is expected to see significant CAGR growth over the coming years, at 7.6%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Apollo Endosurgery, Allurion Technologies, Lexal Srl, Districlass Medical SA, Life Partners Europe, Feng Medical, Medsil, Obalon Therapeutics, Phagia Technologies, PlenSat, ReShape Medical, Silimed, Spatz FGIA Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58845
Report Format:   PDF
Pages:   120
Rating:    4.8 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support